Cirrhosis News and Research

Latest Cirrhosis News and Research

New signature initiative on increasing alcohol taxes could benefit people’s health, reduce mortality

Across the Region, alcohol consumption leads to almost one million deaths each year from a wide range of causes, including cardiovascular diseases, cancers and other noncommunicable diseases (NCDs), as well as infectious diseases and injuries.

28 Feb 2022

Discovery could lead to new treatment approach for people with alcohol-associated liver disease

Investigators at Cedars-Sinai have uncovered a new pathway that helps explain how consuming too much alcohol causes damage to the liver, specifically mitochondrial dysfunction in alcohol-associated liver disease.

22 Feb 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

Discovery may lead to new treatment approach for people with alcohol-associated liver disease

14 Feb 2022

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

In Germany, liver cirrhosis has the highest mortality rate of any chronic disease requiring hospital admission. When diagnosed as a comorbidity of other chronic diseases, liver cirrhosis at least doubles the mortality rate.

12 Feb 2022

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Patients with alcohol-associated cirrhosis have poorer outcomes after ICU discharge, compared to patients with cirrhosis linked to other causes, according to new Mayo Clinic research.

25 Jan 2022

Scientific review highlights the impact of coffee on digestive organs

A new scientific review, published in Nutrients, highlights coffee's effects on digestion and the gut, and its impact on organs involved in digestion.

19 Jan 2022

ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on the use of radiation therapy to treat adult patients with primary liver cancers using external beam radiation therapy (EBRT).

12 Jan 2022

New study shows how regular exercise protects against fatty liver disease

Exercise not only trains the muscles but can also prevent the development of fatty liver. A new study by the German Center for Diabetes Research, Helmholtz Munich and Tübingen University Hospital shows which molecular adaptations, in particular of the liver mitochondria, can be observed in this process.

20 Dec 2021

Physicians who rely only on liver function test can fail to diagnose alcoholic cirrhosis

A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver function test to diagnose alcoholic cirrhosis.

20 Dec 2021

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

A gene that is overexpressed in some aggressive cancers also appears to be key to the excessive cell proliferation that thickens the walls of pulmonary arteries and ultimately causes the right ventricle of the heart to fail, scientists report.

16 Dec 2021

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Metabolic-associated fatty liver disease (MAFLD) is a growing global health challenge and poses a substantial economic burden. A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and MAFLD.

6 Dec 2021

First-of-its-kind PET imaging-based tool developed to detect liver inflammation in NAFLD patients

A UC Davis Health team has developed a first-of-its-kind positron emission tomography (PET) scan imaging-based tool to detect liver inflammation in patients affected with non-alcoholic fatty liver disease.

30 Nov 2021

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

A randomized trial found that video-based, telehealth-delivered exercise and weight loss programs with online educational support improved pain and function in people with knee osteoarthritis and overweight or obesity.

30 Nov 2021

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

25 Nov 2021

Liver cancer can be recognized by RNA fragments in saliva and blood

RUDN University doctors examined markers of liver cancer and found that the disease can be recognized by RNA fragments in saliva and blood. The results are published in Oncotarget.

23 Nov 2021

Monitoring cellular metabolism for NAFLD/NASH liver disease research

In this interview, Jolanta Vidugiriene, a Senior Research Scientist at Promega Corporation, talks to News-Medical about tools for studying metabolism in NAFLD/NASH research.

From Promega Corporation 22 Nov 2021

Red blood cell distribution width as a biomarker for COVID-19

A review highlights the prospects and challenges of RDW as a predictive biomarker for viral infections, with a special focus on COVID-19 and hepatitis.

22 Nov 2021

Bariatric surgery lowers risk of liver disease, heart complications in patients with fatty liver disease

A Cleveland Clinic study shows that patients with obesity and advanced fatty liver disease who had bariatric weight loss surgery significantly lowered their future risk of liver disease complications and serious cardiovascular disease compared with patients who did not have surgery.

11 Nov 2021

Researchers uncover new genetic link to non-alcoholic steatohepatitis

Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.

10 Nov 2021

Cirrhosis News and Research

Latest Cirrhosis News and Research

New signature initiative on increasing alcohol taxes could benefit people’s health, reduce mortality

Discovery could lead to new treatment approach for people with alcohol-associated liver disease

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Discovery may lead to new treatment approach for people with alcohol-associated liver disease

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Scientific review highlights the impact of coffee on digestive organs

ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

New study shows how regular exercise protects against fatty liver disease

Physicians who rely only on liver function test can fail to diagnose alcoholic cirrhosis

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

First-of-its-kind PET imaging-based tool developed to detect liver inflammation in NAFLD patients

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

Liver cancer can be recognized by RNA fragments in saliva and blood

Monitoring cellular metabolism for NAFLD/NASH liver disease research

Red blood cell distribution width as a biomarker for COVID-19

Bariatric surgery lowers risk of liver disease, heart complications in patients with fatty liver disease

Researchers uncover new genetic link to non-alcoholic steatohepatitis

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cirrhosis News and Research

Latest Cirrhosis News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in